Stockscreener 앱 받기
2.14
6.14%
-0.14
시간 외 거래:
2.25
0.11
+5.14%
Sunshine Biopharma Inc 주식(SBFM)의 최신 뉴스
Sunshine Biopharma (SBFM) Holds Near Support After Marginal Gains Amid Biotech Sector VolatilityVirgin POC - newsline.com
SBFM SEC FilingsSunshine Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sunshine Biopharma (SBFM) Slips 6% as Stock Tests Key Support at $2.11RVOL Spike - newsline.com
Sunshine Biopharma Company Profile & Introduction - Moomoo
Sunshine Biopharma (SBFM) Shows Modest Gains, Holds Above Key SupportDelta Hedging - newsline.com
Sunshine Biopharma Inc Stock Short Interest Rises to 68.28% - Quiver Quantitative
Sunshine Biopharma (NASDAQ: SBFM) approves Series C warrant provisions after reverse split - Stock Titan
Sunshine Biopharma (SBFM) Slips 2.44% as Stock Holds Above Key SupportPut Flow Alert - newsline.com
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Pre‑Revenue Biotech Reports Net Loss, Stock Declines - newsline.com
😭😭😭 - Moomoo
$Sunshine Biopharma (SBFM.US)$ :( - Moomoo
SBFM Stock Jumps As Sunshine Biopharma Secures New Drug Approvals - StocksToTrade
Sunshine Biopharma (SBFM) Gains Approval for Generic Rivaroxaban in Canada - GuruFocus
Sunshine Biopharma announces Canadian approval for Rivaroxaban - TipRanks
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) - guardonline.com
Generic Xarelto pill from Sunshine Biopharma wins Canada approval - Stock Titan
Why Sunshine Biopharma (SBFM) stock dropped after hours today - MSN
Sunshine Biopharma Stock Quote, Share Price, News and Analysis - Longbridge
SBFM Q1 2026 Earnings: Reported Loss of -$0.25 Per Share as Clinical Pipeline AdvancesEarnings Call Transcript - newsline.com
Sunshine Biopharma (SBFM) Secures Patent for Coronavirus Treatme - GuruFocus
Sunshine Biopharma Approves Dilutive Share and Warrant Actions - TipRanks
Sunshine Biopharma (SBFM) approves warrant provisions after May 19 offering - Stock Titan
Major holder of Sunshine Biopharma (NASDAQ: SBFM) approves share and Series C warrant terms - Stock Titan
Sunshine Biopharma receives patent for coronavirus treatment compounds By Investing.com - Investing.com South Africa
Sunshine Biopharma receives patent for coronavirus treatment compounds - Investing.com
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology - New Castle News
New coronavirus patent aims to keep treatments working as virus mutates - Stock Titan
Sunshine Biopharma stock tumbles after reverse split announcement - Investing.com
Sunshine Biopharma drops 5.17% after announcing a one-for-ten reverse stock split. - Pluang
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today - Benzinga
Sunshine Biopharma announces 1-for-10 reverse stock split - Investing.com UK
Sunshine Biopharma Announces 1-for-25 Reverse Stock Split Effective May 29, 2026 - geneonline.com
Sunshine Biopharma (SBFM) Implements Reverse Stock Split for Nas - GuruFocus
Sunshine Biopharma stock tumbles after reverse split announcement By Investing.com - Investing.com Australia
Sunshine Biopharma announces 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma down after announcing 1-for-10 reverse stock split - MSN
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - guardonline.com
Sunshine Biopharma Inc. Warrant (SBFMW) Surges Nearly 68%: Key Levels to WatchComposite Profile - newsline.com
Sunshine Biopharma (SBFM) Edges Higher as Shares Hold Above Key Support at $0.40Keltner Channel - newsline.com
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - FinancialContent
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch - FinancialContent
Why is Sunshine Biopharma stock falling Tuesday? - MSN
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Reported Loss Per Share of $0.25, Stock Declines 6.8% - newsline.com
Sunshine Biopharma stock rallies on Canadian approval for generic amoxicillin - MSN
2.11%
자본화:
|
볼륨(24시간):